Westminster Securities Reiterates 'Strong Buy' Rating, Six-Month Price Target of $12.24 and 12-Month Price Target of $15.98 On Medical Technology Systems, Inc. ATLANTA, Feb. 26 /PRNewswire-FirstCall/ -- Westminster Securities Corporation is reiterating its investment and risk ratings on Clearwater, Florida-based Medical Technology Systems, Inc. (American Stock Exchange: MPP) with a "Strong Buy" investment rating, a six-month Target Price of $12.24, a 12-month Target Price of $15.98, and a risk rating of "Moderate" over both time periods. According to Westminster analyst Will Lyons, "We are not aware of any fundamental reasons for the recent weakness in MPP's share price. In our opinion, the current price represents a significant buying opportunity in light of the company's most recent quarterly earnings release and conference call on 2/5/04, in which management indicated a number of positive developments." Included in those developments were the following: - Continued strong revenue and earnings growth. In the December 2004 quarter earnings per share rose 61 percent (to $0.10) on a 25 percent rise in revenues. - Sales of three of the company's innovative, automated OnDemand(TM) pharmaceuticals packaging machine were booked in the December quarter, reflecting increasing interest in this time- and money-saving new product line. We are also encouraged by management's forecast for a substantial increase in MPP's sales of OnDemand(TM) machines in the coming year, ramping up to one semi-automated unit per month and one fully-automated unit per quarter. Our current forecast is for MPP's fully-taxed, fully-diluted earnings per share to rise to US$0.33 and US$0.50 in fiscal years ending 3/31/04 and 3/31/05, respectively. MPP's current share price of $6.85 is 21 X and 14 X these estimates, respectively. Medical Technology Systems, Inc. is North America's largest provider of packaging supplies and equipment for institutional pharmacies. MPP's customers inthe US and abroad -- who package pharmaceuticals for assisted living, medical and other institutions with 100s or 1,000s of residents requiring daily doses of various medications or nutritional supplements in pill or capsule form -- use MPPs innovativeproducts to safely package such medications and supplements more quickly and efficiently than is possible with other packaging options. MPP is not an investment banking client of Westminster Securities Corporation and Westminster Securities Corporation does not make a market in MPP shares. For further information, please contact: William D. Lyons, Director of Equity Research () Richard Louise, Director of Institutional Sales () Westminster Securities Corporation, 3827 Roswell Road, Suite 100-A, Atlanta, Georgia 30062; Phone: (770) 321-6799; Fax: (770) 321-2253 Westminster Securities Corporation is a full service New York Stock Exchange member firm operating in six principal areas: Investment Banking, Equity Research, Execution Services, Clearing and Operations and Institutional and Retail Account Management. Combining the responsiveness of a boutique firm with the financial expertise of a long established institution, Westminster provides its services to corporations, institutions, private clients, and investment professionals worldwide. Founded in 1971, Westminster is a member of the New York Stock Exchange, National Association of Securities Dealers (CRD number 6105), and the Securities Investor Protection Corporation. Westminster is headquartered at 100 Wall Street, New York, with branch offices in Atlanta, New York, Miami, St. Louis, Toronto, Limassol (Cyprus) and Shanghai (People's Republic of China). DATASOURCE: Westminster Securities Corporation CONTACT: William D. Lyons, Director of Equity Research, , or Richard Louise, Director of Institutional Sales, , both of Westminster Securities Corporation, +1-770-321-6799, or fax, +1-770-321-2253 Web site: http://www.westminstersecurities.com/

Copyright